Login

Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Burchill shares his perspective on what makes Mayo Clinic’s approach to ACHD special.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Venture capital firm that invests in start-ups that apply data and technology to disrupt existing industries|David Waxman,Managing Partner,TenOneTen Ventures
00:10:00
Pasqualino Monti Honored at CEO for LIFE Awards 2023 | Pasqualino Monti - CEO of ENAV
00:10:00
Laurent Junique, CEO of TDCX, discusses the outsourced customer experience (CX) market on #NYSEFloorTalk.
00:10:00
John Crespo: Navigating Latin America's Corporate Landscape | John P. Crespo - PARTNER of Morgan, Lewis & Bockius LLP
00:10:00
Understanding the True Cost of a Financial Advisor
00:10:00
Healthcare Investment Trends: Challenges and Opportunities Ahead
00:10:00
Momentus: Revolutionizing Space Infrastructure and Delivery
00:10:00
Meet the Manager: Insights with Xuesong Zhao, Lead Portfolio Manager at Polar Capital Automation & AI Fund
00:10:00
Diversifying Wealth: Srikanth Narayan on Managing Concentrated Stock with Exchange Funds
00:10:00
American Airlines CEO Robert Isom on Reimagining Global Connectivity: Expansion for the Decade Ahead | Robert Isom, CEO, American Airlines Group Inc.
00:10:00
Founder of BlackBoxStocks Inc. , Discusses Company Outlook at the Planet MicroCap Showcase 2019 in Las Vegas | Eric Pharis, Founder, BlackBoxStocks Inc.
00:00:00
Pierre Laurin, CEO, ProMetic Life Sciences Inc

© 2026 Nehu